Article info
Short report
CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinoma
- Correspondence to Dr Francesco A Mauri, Department of Histopathology, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0HS, UK; f.mauri{at}imperial.ac.uk
Citation
CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinoma
Publication history
- Received June 21, 2012
- Revised August 12, 2012
- Accepted September 12, 2012
- First published October 19, 2012.
Online issue publication
February 21, 2013
Article Versions
- Previous version (19 October 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions